Table 2. Factors associated with increased attenuation index (steatosis).
Data are shown as numbers (percentage), or mean ± standard error of mean.
BMI, body mass index; Hb, hemoglobin; TLC, total leukocyte count; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyltransferase; ALP, alkaline phosphatase; CHOL, cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low density lipoprotein; UA, uric acid; HOMA-IR, homeostasis model assessment of insulin resistance; HBV, hepatitis B virus; DNA, deoxyribonucleic acid
| Variable | Steatosis present N=161, 70% | Steatosis absent N=69, 30% | P-value |
| AGE (years ) | 38.08±10.30 | 33.8±11.5 | 0.00 |
| BMI (kg/m2) | 28.3±4.4 | 24.9±4.7 | 0.00 |
| WAIST (cm) | 96.7±11.0 | 89.8±10.0 | 0.00 |
| WEIGHT (kg) | 84.0±15.7 | 73.2±14.4 | 0.00 |
| HB (g/dl) | 13.9±1.62 | 14.1±1.81 | 0.52 |
| TLC (x109/liter). | 7.18±1.80 | 6.8±1.9 | 0.20 |
| PLATELETS (x109/liter). | 253.9±65.5 | 226.1±69.01 | 0.005 |
| ALT (u/l) | 52.39±27.5 | 50.9±36.2 | 0.003 |
| GGT (u/l) | 43.2±36.2 | 30.7±20.0 | 0.001 |
| AST (u/l) | 35.6±14.8 | 35.6±19.07 | 0.041 |
| ALP (u/l) | 87.9±39.6 | 87.4±39.9 | 0.92 |
| ALBUMIN (g/dl) | 4.03±0.23 | 4.00±0.28 | 0.35 |
| CR (mg/dl) | 0.74±0.44 | 0.72±0.23 | 0.75 |
| CHOL (mg/dl) | 177.9.2±34.1 | 163.7±35.7 | 0.005 |
| TG (mg/dl) | 160.9±80.04 | 151.84±92.2 | 0.45 |
| HDL (mg/dl) | 40.57±8.78 | 42.4±11.04 | 0.178 |
| LDL (mg/dl) | 102.2±31.3 | 93.4±30.1 | 0.049 |
| VLDL (mg/dl) | 21.5±14.4 | 18.97±12.93 | 0.176 |
| UA (mg/dl) | 5.12±1.35 | 4.28±1.14 | 0.000 |
| ELASTICITY (kpa) | 9.34±6.17 | 9.01±10.06 | 0.061 |
| INSULIN (µIU/mL) | 12.98±6.67 | 9.02±5.59 | 0.000 |
| HOMA-IR | 3.02±1.61 | 2.03±1.24 | 0.000 |
| HBV DNA (IU/ml) | 4502857.44±29470083.3 | 8085400.29±34973918.8 | 0.607 |